Welcome : Guest

NEXT GENERATION SEQUENCERS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Next Generation Sequencers in US$ Thousand. The Global market is additionally analyzed by the following End-Use Segments: Pharmaceutical/Biotech, Industrial, and Government/Academia. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 93 companies including many key and niche players such as -

Agilent Technologies Inc.
Becton, Dickinson and Company
Fluidigm Corporation
Genomatix GmbH
Illumina, Inc.

Click here to request a full list of companies covered in the report...

Code: MCP-6811
Price: $4500
Companies: 93
Pages: 295
Date: March 2017
Market Data Tables: 47
  Status: * New Report



TABLE OF CONTENTS


  NEXT GENERATION SEQUENCERS (Complete Report) Pages : 295   | $4500

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Next Generation Sequencing Techniques Transform the Genomics Space.....II-11$100
   Next Generation Sequencers (NGS): A High-Throughput Sequencing Technology.....II-22$200
   US Leads the NGS Market, Asia-Pacific to Foster Future Growth.....II-4
Academic & Research Dominates NGS Market.....II-4
1$100
   Oncology Testing – The Application with Most Promising Opportunities for NGS
  Technology.....II-5
1$100
   Declining Cost of Sequencing to Fuel Adoption of NGS Systems.....II-6 1$100
   Table 1: Cost Per Genome Sequencing in $ for the Years 2000 through 2016 (includes corresponding Graph/Chart).....II-7
After Dramatic Price Declines, Is NGS Market Positioned for Further Disruption?.....II-7
2$350
   A Highly Competitive Marketplace.....II-9
Illumina Leads the Global NGS Market.....II-9
1$100
   Illumina’s NGS Instruments Portfolio – A Comparison.....II-10
Table 2: Leading Vendors in the Global NGS Market (2016E): Percentage Breakdown of Installed Base for Illumina, Life Technologies/Thermo Fisher, and Others (includes corresponding Graph/Chart).....II-10
1$350
   Table 3: Leading Players in the Global NGS Instruments & Consumables Market (2016E): Percentage Breakdown of Revenues for Illumina, Life Technologies/Thermo Fisher, Pacific Biosciences and Others (includes corresponding Graph/Chart).....II-11
A Glance at the Major NGS Platforms in Use.....II-11
1$350
   Key NGS Platforms on the Market.....II-121$100
   Expanding Applications of NGS Technology.....II-13
NGS Revolutionizes Drug Discovery and Development Space.....II-13
3$300
   Genetic Information offered by NGS Aids in Drug Development Process.....II-16
Revolutionary Capabilities of NGS Technology to Play a Vital Part in Advancement of
  Precision Medicine.....II-16
3$300
   Rising Incidences of Cancer & Benefits of Personalized Cancer Therapy to Propel NGS
  Market.....II-19
2$200
   Comparison of Sanger Sequencing, Real-time PCR Sequencing and Next Generation
  Sequencing Methods for Identification of Driver Mutations.....II-21
Key Cancer Statistics.....II-21
Table 4: Worldwide Incidence of Cancer: Number of New Cases Diagnosed for the Years 2013, 2020 & 2030 (includes corresponding Graph/Chart).....II-21
1$350
   Table 5: New Cancer Cases in the World by Affected Site (2012) (In Thousands) (includes corresponding Graph/Chart).....II-22

Table 6: Common Cause of Cancer Deaths Worldwide - Number of Deaths due to Select Types of Cancer for 2015 (includes corresponding Graph/Chart).....II-22
1$350
   NGS Emerges as a Game Changing Technology for Precision Oncology.....II-231$100
   Personalized Medicine: Growing Prominence of NGS in Providing Customized Treatments to
  Patients.....II-24
1$100
   Growing Significance of NGS in Enabling Personalized Oncology – Timeline of Major
  Developments in Sequencing Technologies & Applications Related to Oncology.....II-25
Personal Genomics Services – Blessing or Bane?.....II-25
1$100
   NGS Technology Drives RNA Sequencing in Transcriptomics.....II-262$200
   Longer Reach of a Read: A Key Feature Considered for Sequencing.....II-28
qPCR – The Core Technique in NGS Technique.....II-28
1$100
   Development of New Systems & Platforms to Fuel NGS Utilization.....II-29
Advancements in Next Generation Sequencing (NGS) Technology Fuel Adoption.....II-29
Development Efforts Intensify in Long-Read Sequencing.....II-29
1$100
   Single-Cell Genomics: A Promising Application of NGS Technology.....II-301$100
   Shift from Tumor Biopsies to Cancer Liquid Biopsies.....II-31
NGS Enhances Study of Antimicrobial Resistance.....II-31
1$100
   Effective Use of NGS Tools in Public Healthcare Systems.....II-321$100
   E-Infrastructure for Storage & Analysis of NGS Data.....II-331$100
   Explosive Growth in Sequencing Data Drives Focus onto Cloud Computing.....II-341$100
   NGS Hold an Edge Over CE Sequencing Method.....II-35
Standardization of NGS Technique: A Critical Requirement for Wider Adoption.....II-35
2$200
   Challenges Confronting High-throughput Sequencing Market.....II-371$100
   High Machine Costs and Licensure Fees.....II-38
Lack of Skilled Personnel.....II-38
Absence of Regulatory Framework.....II-38
1$100
   Limited Access to Scientific Literature and Internet.....II-39
Suboptimal Outsourcing Services.....II-39
Regulations Related to NGS-Based Tests.....II-39
1$100
   Innovative Technologies.....II-40
Nanopore Sequence Technology.....II-40
Single-Molecule Real-Time technology (SMRT).....II-40
Direct Genomics’ Single Molecule Sequencing.....II-40
1$100
   TruSPADES Simplifies Metagenomics Sequencing.....II-41
GnuBIO Platform.....II-41
1$100
   Electron Microscopy DNA Sequencing.....II-421$100
   FRET-based DNA Sequencing.....II-43
Identification/Sequencing using Mechanical Properties.....II-43
MALDI-TOF MS.....II-43
1$100
   RNAP Sequencing Method.....II-44
Tunneling Currents DNA Sequencing.....II-44
qPCR-Driven Library Quantitation Saves Time and Overheads.....II-44
1$100
   Achieving Trans-Block Uniformity.....II-451$100
   Enhancing qPCR Precision.....II-461$100
   Sanger Sequencing (Dideoxy Sequencing).....II-471$100
   Evolution of Next Generation Sequencing.....II-48
NGS versus Microarrays.....II-48
Important Factors to Consider Before Choosing NGS Platforms.....II-48
1$100
   NGS – Major Application Areas.....II-49
Whole Genome Sequencing.....II-49
Exome sequencing.....II-49
Targeted Resequencing.....II-49
RNA sequencing (RNA-Seq).....II-49
1$100
   Chromatin immunoprecipitation sequencing (ChIP-Seq).....II-501$100
   QIAGEN Launches Novel QIAseq NGS Panels.....II-51
BD Launches BD CLiC™ System.....II-51
Immucor and Sirona Genomics Launch MIA FORA NGS.....II-51
bioMérieux and Illumina Launch bioMérieux EpiSeq NGS Service.....II-51
Bioline Introduces JetSeq™ Kit for NGS Sample Preparation.....II-51
Oxford Gene Technology Launches SureSeq™ NGS Solutions.....II-51
1$100
   GENEWIZ Launches FuzeSeq™ Antibody Sequencing Technology.....II-52
Sage Science Launches PippinHT Automated Instruments for Use with NGS.....II-52
BGI Tech to Launch Two Ranges of NGS – X Bio and Intelligen.....II-52
Thermo Fisher Scientific Introduces Clinical NGS Oncology Quality Control.....II-52
Vela Diagnostics Announces Pre-launch of Automated NGS.....II-52
Rubicon Genomics Launches PicoPLEX™ DNA-seq Kits for Use with NGS Platforms.....II-52
1$100
   Mayo Clinic Collaborates with Illumina on NGS.....II-53
Sophia Genetics Enters into Partnership with Illumina.....II-53
Novogene Enters into Collaboration with AITbiotech.....II-53
Natera Extends Supply Agreement with Illumina.....II-53
ArcherDX Enters into Collaboration with Illumina.....II-53
TBUSH to Acquire WaferGen Bio-systems.....II-53
Advanced Biological Laboratories Signs Distribution Agreement with Thermo Fisher
  Scientific.....II-53
1$100
   Bio-Rad Enters into Partnership with Illumina.....II-54
SYGNIS AG Signs Distribution Agreement with Lucigen.....II-54
Almac Diagnostics Enters into Collaboration with Illumina.....II-54
Roche Acquires Kapa Biosystems.....II-54
QIAGEN Expands Partnership with BGI.....II-54
Intel Enters into Partnership with Edico Genome.....II-54
Illumina Enters into Partnership with Merck Serono.....II-54
1$100
   Lockheed Martin and Illumina Enter into Partnership.....II-55
WuXi PharmaTech Acquires NextCODE Health.....II-55
Roche Acquires Bina Technologies.....II-55
CollabRx Enters into Partnership with Cartagenia.....II-55
New England Biolabs and Directed Genomics Enter into Partnership.....II-55
Reprogenetics Partners with Illumina.....II-55
BD Acquires GenCell Biosystems.....II-55
1$100
   AB SCIEX and Illumina Enter into OneOmics™ Partnership Project.....II-56
Thermo Fisher Scientific, GSK, and Pfizer Enter into Agreement to Develop NGS.....II-56
AstraZeneca Collaborates with Illumina.....II-56
Roche Acquires Genia Technologies.....II-56
1$100
   Agilent Technologies Inc. (US).....II-57
Becton, Dickinson and Company (BD) (US).....II-57
1$100
   Fluidigm Corporation (US).....II-58
Genomatix GmbH (Germany).....II-58
1$100
   Illumina, Inc. (US).....II-59
Oxford Gene Technology (UK).....II-59
1$100
   Oxford Nanopore Technologies (UK).....II-60
Pacific Biosciences of California, Inc. (US).....II-60
QIAGEN N.V. (The Netherlands).....II-60
1$100
   RainDance Technologies, Inc. (US).....II-61
Roche Sequencing (US).....II-61
1$100
   Shenzhen BGI Diagnosis Co., Ltd. (China).....II-62
Thermo Fisher Scientific, Inc. (US).....II-62
2$200
   Table 7: World Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-641$350
   Table 8: World Historic Review for Next Generation Sequencers by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-651$350
   Table 9: World 14-Year Perspective for Next Generation Sequencers by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....II-661$350
   Table 10: World Recent Past, Current & Future Analysis for Next Generation Sequencers by End-Use Industry - Pharmaceuticals/Biotech, Industrial, and Government/Academia Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-671$350
   Table 11: World Historic Review for Next Generation Sequencers by End-Use Industry - Pharmaceuticals/ Biotech, Industrial, and Government/Academia Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-681$350
   Table 12: World 14-Year Perspective for Next Generation Sequencers by End-Use Industry - Percentage Breakdown of Dollar Sales for Pharmaceuticals/Biotech, Industrial, and Government/Academia Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....II-691$350
   A. Market Analysis.....III-1
Market Overview.....III-1
FDA Regulations on NGS-Based Tests.....III-1
1$75
   Sequencing Applications Drive the US Genomics Market.....III-2
NGS for Clinical Oncology – A Promising Area of Growth.....III-2
1$75
   Product Launches.....III-31$75
   Strategic Corporate Developments.....III-43$225
   Select Key Players.....III-74$300
   B. Market Analytics.....III-11
Table 13: US Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-11
1$200
   Table 14: US Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-121$200
   Market Analysis.....III-13
Table 15: Canadian Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-13
1$200
   Table 16: Canadian Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-141$200
   A. Market Analysis.....III-15
Current and Future Analysis.....III-15
Strategic Corporate Development.....III-15
B. Market Analytics.....III-15
Table 17: Japanese Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-15
1$200
   Table 18: Japanese Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-161$200
   A. Market Analysis.....III-17
Market Overview.....III-17
1$75
   B. Market Analytics.....III-18
Table 19: European Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of European Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-18
1$200
   Table 20: European Historic Review for Next Generation Sequencers by Geographic Region/Country - France, Germany, Italy, UK, Spain, Russia, and Rest of European Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-191$200
   Table 21: European 14-Year Perspective for Next Generation Sequencers by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of European Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-201$200
   Market Analysis.....III-21
Table 22: French Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-21
1$200
   Table 23: French Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-221$200
   A. Market Analysis.....III-23
Current and Future Analysis.....III-23
Genomatix GmbH – A Key Player.....III-23
1$75
   B. Market Analytics.....III-24
Table 24: German Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-24
1$200
   Table 25: German Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-251$200
   Market Analysis.....III-26
Table 26: Italian Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-26
1$200
   Table 27: Italian Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-271$200
   A. Market Analysis.....III-28
Current and Future Analysis.....III-28
Product Launch.....III-28
Strategic Corporate Development.....III-28
Select Key Players.....III-28
1$75
   B. Market Analytics.....III-29
Table 28: UK Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-29
1$200
   Table 29: UK Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-301$200
   Market Analysis.....III-31
Table 30: Spanish Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-31
1$200
   Table 31: Spanish Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-321$200
   Market Analysis.....III-33
Table 32: Russian Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-33
1$200
   Table 33: Russian Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-341$200
   A. Market Analysis.....III-35
Current and Future Analysis.....III-35
Product Launch.....III-35
Strategic Corporate Developments.....III-35
1$75
   QIAGEN N.V. (Netherlands) – A Key Player.....III-361$75
   B. Market Analytics.....III-37
Table 34: Rest of European Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-37
1$200
   Table 35: Rest of European Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-381$200
   Market Analysis.....III-39
Table 36: Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region/Country - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-39
1$200
   Table 37: Asia-Pacific Historic Review for Next Generation Sequencers by Geographic Region/Country - China, and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-401$200
   Table 38: Asia-Pacific 14-Year Perspective for Next Generation Sequencers by Geographic Region/Country - Percentage Breakdown of Dollar Sales for China, and Rest of Asia-Pacific Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-411$200
   A. Market Analysis.....III-42
Current and Future Analysis.....III-42
Strategic Corporate Development.....III-42
Shenzhen BGI Diagnosis Co., Ltd. – A Key Player.....III-42
1$75
   B. Market Analytics.....III-43
Table 39: Chinese Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-43
1$200
   Table 40: Chinese Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-441$200
   A. Market Analysis.....III-45
Current and Future Analysis.....III-45
Strategic Corporate Development.....III-45
B. Market Analytics.....III-45
Table 41: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-45
1$200
   Table 42: Rest of Asia-Pacific Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-461$200
   Market Analysis.....III-47
Table 43: Latin American Recent Past, Current & Future Analysis for Next Generation Sequencers by Geographic Region/Country - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-47
1$200
   Table 44: Latin American Historic Review for Next Generation Sequencers by Geographic Region/Country - Brazil, and Rest of Latin America Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-481$200
   Table 45: Latin American 14-Year Perspective for Next Generation Sequencers by Geographic Region/Country - Percentage Breakdown of Dollar Sales for Brazil, and Rest of Latin America Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart).....III-491$200
   Market Analysis.....III-50
Table 46: Rest of World Recent Past, Current & Future Analysis for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-50
1$200
   Table 47: Rest of World Historic Review for Next Generation Sequencers Market Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-511$200
  
Total Companies Profiled: 94 (including Divisions/Subsidiaries - 104)

Region/Country Players

The United States 61 Canada 3 Japan 2 Europe 27 France 1 Germany 7 The United Kingdom 5 Rest of Europe 14 Asia-Pacific (Excluding Japan) 11
Click here to request a full table of contents and more details on this project.